| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8244039 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 7 Pages |
Abstract
Conclusion: High-dose 3DCRT is a noninvasive, well-tolerated modality that is highly suitable for the treatment of small HCCs in cirrhotic patients, with promising results. However, additional trials are needed to optimize this technique and formally compare it with the usual curative approaches.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Françoise M.D., Ph.D., Nicolas M.D., Christophe M.D., Abdul M.D., Mustapha Khodri, Christian M.D., Ph.D., Philippe M.D., Ph.D.,